Linezolid B. Braun

Linezolid, the active ingredient in Linezolid B. Braun, is an oxazolidinone antibiotic presented as an intravenous solution for intravenous use. It treats infections caused by Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), in adult and pediatric patients where indicated.

GNH USA supplies Linezolid B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Linezolid is an oxazolidinone antibiotic used to treat serious Gram‑positive bacterial infections.

- Skin and soft‑tissue infections: effective against MRSA and other resistant organisms. - Hospital‑acquired pneumonia (including ventilator‑associated): provides coverage for resistant Gram‑positive pathogens. - Complicated intra‑abdominal infections: used when Gram‑positive coverage is required, often in combination with other agents.

Linezolid may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Peripheral neuropathy: numbness or tingling in extremities. - Optic neuritis: visual disturbances, possible vision loss. - Serotonin syndrome: risk when combined with serotonergic agents. - Myelosuppression: bone‑marrow suppression affecting blood cells. - Lactic acidosis: metabolic acidosis with elevated lactate levels.

When prescribing Linezolid, clinicians should consider several safety measures.

- Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: assess liver enzymes regularly during treatment. - Concomitant serotonergic agents: avoid due to risk of serotonin syndrome. - Long‑term therapy: perform periodic complete blood counts. - Risk of lactic acidosis: evaluate metabolic status in patients with mitochondrial disorders. - Store at ambient temperature: keep in original container, protect from light and moisture.

Linezolid interacts with several drug classes, requiring careful management.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): may precipitate serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin toxicity. - Rifampicin: reduces linezolid plasma concentrations. - Erythromycin: may increase linezolid levels. - Tyramine‑rich foods: risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR, monitor coagulation. - Theophylline: may increase theophylline serum levels. - Anticonvulsants (e.g., carbamazepine): may affect linezolid metabolism.